The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD): (553842013-001)
Abstract
Objectives To assess efficacy, comparative effectiveness, and harms of psychological and pharmacological treatments for adults with posttraumatic stress disorder (PTSD). Data sources MEDLINE®, Cochrane Library, PILOTS, International Pharmaceutical Abstracts, CINAHL®, PsycINFO®, Web of Science, Embase, U.S. Food and Drug Administration Web site, and reference lists of published literature (January 1980–May 2012). Review methods Two investigators independently selected, extracted data from, and rated risk of bias of relevant trials. We conducted quantitative analyses using random-effects models to estimate pooled effects. To estimate medications’ comparative effectiveness, we conducted a network meta-analysis using Bayesian methods. We graded strength of evidence (SOE) based on established guidance. Results We included 92 trials of patients, generally with severe PTSD and mean age of 30s to 40s. High SOE supports efficacy of exposure therapy for improving PTSD symptoms (Cohen’s d −1.27; 95% confidence interval, −1.54 to −1.00); number needed to treat (NNT) to achieve loss of diagnosis was 2 (moderate SOE). Evidence also supports efficacy of cognitive processing therapy (CPT), cognitive therapy (CT), cognitive behavioral therapy (CBT)-mixed therapies, eye movement desensitization and reprocessing (EMDR), and narrative exposure therapy for improving PTSD symptoms and/or achieving loss of diagnosis (moderate SOE). Effect sizes for reducing PTSD symptoms were large (e.g., 28.9- to…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rates of participants who no longer met PTSD diagnosis criteria ranged from 30% to 97% and 51% more participants treated with CPT achieved loss of PTSD diagnosis, compared to waitlist, self-help booklet and usual care control groups (Jonas et al., 2013).”
From Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions (2018) · cites this paper as Jonas et al., 2013
In the citing paper
“In addition, 66% more participants treated with exposure therapy achieved loss of PTSD diagnosis than in waitlist control groups (Jonas et al., 2013).”
From Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions (2018) · cites this paper as Jonas et al., 2013
In the citing paper
“Among PE participants, 41% to 95% lost their PTSD diagnosis at the end of treatment (Jonas et al., 2013).”
From Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions (2018) · cites this paper as Jonas et al., 2013
In the citing paper
“Rates of participants who no longer met PTSD diagnosis criteria ranged from 30% to 97% and 51% more participants treated with CPT achieved loss of PTSD diagnosis, compared to waitlist, self-help booklet and usual care control groups (Jonas et al., 2013).”
From Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions (2018) · cites this paper as Jonas et al., 2013
Citations
Cites
Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care
Hoge, C. W., Castro, C. A., Messer, S. C., McGurk, D., Cotting, D. I., & Koffman, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040603 · Cited by 4,778
Clinician-administered PTSD scale: A review of the first ten years of research
Weathers, F. W., Keane, T. M., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1029 · Cited by 1,901 · cited 1×
“For example, some suggest that a reduction of 15 points on the Clinician-Administered PTSD Scale (CAPS) constitutes a clinically significant reduction.(27) However, this cutoff has not been validated and is somewhat uncertain.”
Background(2008) · RAND Corporation eBooks · doi:10.7249/mg720 · Cited by 1,712 · cited 1×
“, the Veterans Health Administration [VA]) have identified PTSD as a priority area for quality improvement and comparative effectiveness research; these decisions are based, in part, on evidence of higher rates of PTSD among service members returning from operations in Afghanistan and Iraq than previously reported, an…”
BackgroundFreeman, A. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1112 · Cited by 1,666
Seal (2007) · doi:10.1001/archinte.167.5.476 · Cited by 936 · cited 1×
“6 percent for those who fought in Iraq (see Figure 3).(8)”
BackgroundFoa, E. B., Hembree, E. A., Cahill, S. P., Rauch, S. A. M., Riggs, D. S., Feeny, N. C., & Yadin, E. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.5.953 · Cited by 931
(2000) · PubMed · Cited by 858
The theory and practice of group psychotherapy, 4th ed.
Yalom, I. D., & Leszcz, M. (1995) · Cited by 706
The Psychological Risks of Vietnam for U.S. Veterans: A Revisit with New Data and Methods
Dohrenwend, B. P., Turner, J. B., Turse, N. A., Adams, B. G., Koenen, K. C., & Marshall, R. (2006) · Science · doi:10.1126/science.1128944 · Cited by 689 · cited 2×
“1 percent among Vietnam veterans.(7) Surveys of military personnel returning from operations in Afghanistan and Iraq have yielded estimates ranging from 6.”
Background(1993) · Medical Entomology and Zoology · Cited by 611
Cited by
Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions
Watkins, L. E., Sprang, K. R., & Rothbaum, B. O. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00258 · Cited by 563
“In addition, 66% more participants treated with exposure therapy achieved loss of PTSD diagnosis than in waitlist control groups (Jonas et al., 2013).”
BackgroundMethodInfluentialMental Health Response to Community Disasters: A Systematic Review
North, C. S., & Pfefferbaum, B. (2013) · JAMA · doi:10.1001/jama.2013.107799 · Cited by 549
Lewis, C., Roberts, N. P., Andrew, M., Starling, E., & Bisson, J. I. (2020) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1729633 · Cited by 460
“…the traumatic event and those that aim to reduce traumatic stress symptoms without directly targeting the traumamemory or related thoughts, with the strongest evidence for the effect of those with a trauma-focus (Bisson et al., 2013; Bradley et al., 2005; Cusack et al., 2006; Jonas et al., 2013).”
BackgroundPharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis
Hoskins, M., Pearce, J., Bethell, A., Dankova, L., Barbui, C., Tol, W. A., van Ommeren, M., de Jong, J., Seedat, S., Chen, H., et al. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.148551 · Cited by 418
Lewis, C., Roberts, N. P., Gibson, S., & Bisson, J. I. (2020) · European Journal of Psychotraumatology · doi:10.1080/20008198.2019.1709709 · Cited by 382
“However, there is evidence that the absence of a trauma-focus results in poorer outcomes (Bisson et al., 2013; Bradley et al., 2005; Jonas et al., 2013).”
Background
Metadata
- Authors
- Jonas, D. E., Cusack, K., Forneris, C., Wilkins, T. M., Sonis, J., Middleton, J. C., Feltner, C., Meredith, D., Cavanaugh, J., Brownley, K. A., Olmsted, K. R., Greenblatt, A., Weil, A., & Gaynes, B. N.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- ORCID
- Venue
- PsycEXTRA Dataset
- Published
- 2013
- OpenAlex
- W1511020442
- Cited by
- 178
- References
- 26
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 14 · 2022: 8 · 2021: 21 · 2020: 18 · 2019: 14 · 2018: 21 · 2017: 21 · 2016: 22 · 2015: 11 · 2014: 10 · 2013: 5
- Type
- dataset
- Language
- en
- Open access
- closed
- Locations
- PsycEXTRA Dataset (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- post-traumatic stress disorder, psychological intervention, pharmacotherapy, exposure therapy, cognitive processing therapy, cognitive behavioral therapy, EMDR, narrative exposure therapy, selective serotonin reuptake inhibitors, paroxetine, venlafaxine, topiramate, risperidone, depression, functional disability, comparative effectiveness, treatment harms, network meta-analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD): (553842013-001). https://app.cochat.ai/papers/10.1037/e553842013-001
- The paper
- Jonas, D. E., Cusack, K., Forneris, C., Wilkins, T. M., Sonis, J., Middleton, J. C., Feltner, C., Meredith, D., Cavanaugh, J., Brownley, K. A., Olmsted, K. R., Greenblatt, A., Weil, A., & Gaynes, B. N. (2013). Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD): (553842013-001). PsycEXTRA Dataset. https://doi.org/10.1037/e553842013-001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.